The largest holder of MetLife stock is MetLife Policyholder Trust, with 102.1 million shares (16.07% of the company), worth about $9.72 billion as of September 25, 2026. The 10 largest holders together own 53.4%.
In Q2 2026, 1,527 institutional holdings reports listed 559.0 million shares worth $41.90 billion, up 15.7% in shares from Q1 2026.
Insiders reported 127 transactions in the last two years: 2 sales worth $3.83 million and no purchases. The newest one on file is from September 8, 2026 (Kennard William E, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 8, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| MetLife Policyholder Trust | 102.1 million | 16.07% | $9.7B |
| Dodge & Cox | 48.4 million | 7.62% | $4.6B |
| BlackRock Advisors LLC | 38.8 million | 6.10% | $3.7B |
| Vanguard Capital Management LLC | 35.5 million | 5.58% | $3.4B |
| Vanguard Portfolio Management LLC | 30.0 million | 4.73% | $2.9B |
| State Street Corporation | 25.3 million | 3.99% | $2.4B |
| T. Rowe Price International Ltd. | 21.3 million | 3.35% | $2.0B |
| Geode Capital Management LLC | 13.3 million | 2.09% | $1.3B |
| Eaton Vance Management | 12.5 million | 1.97% | $1.2B |
| BlackRock Life Ltd. | 12.0 million | 1.88% | $1.1B |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,527 | 559.0 million | $41.9B |
| Q1 2026 | 1,451 | 483.0 million | $34.2B |
| Q4 2025 | 1,518 | 495.0 million | $39.0B |
| Q3 2025 | 1,448 | 488.0 million | $40.1B |
| Q2 2025 | 1,490 | 495.0 million | $39.8B |
| Q1 2025 | 1,492 | 498.0 million | $39.9B |
| Q4 2024 | 1,498 | 506.0 million | $41.5B |
| Q3 2024 | 1,411 | 531.0 million | $43.8B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Kennard William E | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $28,077 |
| Glaser Daniel S | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $955 |
| Hubbard Robert Glenn | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $59,019 |
| Hay Laura J | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $3,724 |
| Mumenthaler Christian Stephane | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $2,006 |
| Mckenzie Diana L | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $14,994 |
| Tadros Ramy | Sep 8, 2026 | Officer | Stock Award(Grant) at price 95.50 per share. | $10,982 |
| Johnson Jeh Charles | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $5,634 |
| Harris Carla A | Sep 8, 2026 | Director | Stock Award(Grant) at price 95.50 per share. | $4,011 |
| Kennard William E | Jun 16, 2026 | Director | Stock Award(Grant) at price 87.40 per share. | $51,304 |
| Glaser Daniel S | Jun 16, 2026 | Director | Stock Award(Grant) at price 87.40 per share. | $51,304 |
| Hubbard Robert Glenn | Jun 16, 2026 | Director | Stock Award(Grant) at price 87.40 per share. | $88,798 |
Newest 12 of 127 insider transactions in the last two years.
MetLife Policyholder Trust, with 16.07% of the company (as of September 25, 2026). Next: Dodge & Cox (7.62%) and BlackRock Advisors LLC (6.10%).
1,527 institutional holdings reports listed MetLife shares in Q2 2026, 559.0 million shares in all worth $41.90 billion.
In the last two years insiders reported 2 sales and no purchases (127 transactions in all); the newest on file is from September 8, 2026.